HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Regulation/Legislation (Wellness)

Set Alert for Regulation {Wellness}

FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework

Commissioner Gottlieb appointed working group at FDA to evaluate agency's existing structure and strategies for oversight of supplement sector. Group's findings will determine extent of potential changes in regulatory authorities agency will ask members of Congress to establish through legislation. Action plan expected in early 2019.

United States Wellness Dietary Supplements

Recruitment Begins For UK Health Claims Committee In Preparation For Brexit

With time running out for the UK to ratify its Withdrawal Agreement from the EU, the government has begun recruitment for a new Nutrition and Health Claims Committee which will take on the activities of EFSA in the event of a no deal.
Wellness Regulation Dietary Supplements


Set Alert for Regulation {Wellness}

Latest From Wellness & Regulation

Dietary Supplement Firms' Sun Protection Claims Scorched In NAD Review

National Advertising Division advises firms marketing supplements with claims to protect skin from sun rays to discontinue statements similar to claims made by four supplement firms FDA warned in May. Novahue and Dermatology Industry both disagreed with NAD but would comply with its recommendations.

Wellness Health

TummyZen Firm Appeals After Heartburn Claims Don't Settle Well In NAD Review

Eli Consumer Healthcare is latest supplement marketer National Advertising Division has advised that tests of separate ingredients do not support claims for a whole product. Following NADs review of TummyZen claims on challenge by Tums firm GlaxoSmithKline, Eli Consumer appeals NAD's recommendations to discontinue claims that its supplement “stops acid production,” is “acid inhibiting,” “halts the secretion of chloride ions in your parietal cells to regulate the release of acid into your stomach,” “supports stomach lining” and is “long lasting."

Wellness Health

UK To Overhaul Health Claims Approval In Event of 'No Deal' Brexit

In the event of a no deal Brexit, new health claims approved by EFSA will not be valid in the UK. Firms will need to seek approval from the new UKNHCC body.

Wellness Dietary Supplements
See All